AAAAAA
Results:
1-15
|
Results: 15
Urologic oncology: extraordinary opportunities for discovery - New initiatives in radiation oncology
Authors:
Coleman, CN
Citation: Cn. Coleman, Urologic oncology: extraordinary opportunities for discovery - New initiatives in radiation oncology, UROL ONCOL, 6(5), 2001, pp. 185-188
Authors:
Coleman, CN
Citation: Cn. Coleman, Investing in our future: Listening to those who will take us where we needto go, INT J RAD O, 49(5), 2001, pp. 1211-1211
Authors:
Coleman, CN
Cumberlin, R
Citation: Cn. Coleman et R. Cumberlin, We're from the government and we're here to help you, INT J RAD O, 49(3), 2001, pp. 617-618
Authors:
Coleman, CN
Citation: Cn. Coleman, International Conference on Translational Research and Preclinical Strategies in Radio-Oncology (ICTR) - Conference summary, INT J RAD O, 49(2), 2001, pp. 301-309
Authors:
Hussey, DH
Sagerman, RH
Halberg, F
Dubey, A
Coleman, CN
Citation: Dh. Hussey et al., Report of the 1997 SCAROP Survey on Resident Training, ACAD RADIOL, 7(3), 2000, pp. 176-183
Authors:
Coleman, CN
Citation: Cn. Coleman, Biological basis of radiation sensitivity Part 2: Cellular and molecular determinants of radiosensitivity - Reviewed, ONCOLOGY-NY, 14(5), 2000, pp. 757
Authors:
Coleman, CN
Govern, FS
Svensson, G
Mitchell, R
Chaffey, JT
Citation: Cn. Coleman et al., The Harvard Joint Center for Radiation Therapy, 1968-1999: A unique concept and its relationship to the prevailing times in academic medicine, INT J RAD O, 47(5), 2000, pp. 1357-1369
Authors:
Palayoor, ST
Youmell, MY
Calderwood, SK
Coleman, CN
Price, BD
Citation: St. Palayoor et al., Constitutive activation of I kappa B kinase alpha and NF-kappa B in prostate cancer cells is inhibited by ibuprofen, ONCOGENE, 18(51), 1999, pp. 7389-7394
Authors:
Coleman, CN
Mason, T
Hooker, EP
Robinson, SE
Citation: Cn. Coleman et al., Developmental effects of intermittent prenatal exposure to 1,1,1-trichloroethane in the rat, NEUROTOX T, 21(6), 1999, pp. 699-708
Authors:
Coleman, CN
Mitchell, JB
Citation: Cn. Coleman et Jb. Mitchell, Clinical radiosensitization: Why it does and does not work, J CL ONCOL, 17(1), 1999, pp. 1-3
Authors:
D'Amico, AV
Whittington, R
Malkowicz, SB
Fondurulia, J
Chen, MH
Kaplan, I
Beard, CJ
Tomaszewski, JE
Renshaw, AA
Wein, A
Coleman, CN
Citation: Av. D'Amico et al., Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer, J CL ONCOL, 17(1), 1999, pp. 168-172
Authors:
Shulman, LN
Buswell, L
Riese, N
Doherty, N
Loeffler, JS
von Roemeling, RW
Coleman, CN
Citation: Ln. Shulman et al., Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors, INT J RAD O, 44(2), 1999, pp. 349-353
Authors:
Coleman, CN
Citation: Cn. Coleman, Molecular biology in radiation oncology - Radiation oncology perspective of BRCA1 and BRCA2, ACTA ONCOL, 38, 1999, pp. 55-59
Authors:
Stevenson, MA
Zhao, MJ
Asea, A
Coleman, CN
Calderwood, SK
Citation: Ma. Stevenson et al., Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repressRSK2-dependent transcription of cyclic AMP response element binding protein- and NF-kappa B-responsive genes, J IMMUNOL, 163(10), 1999, pp. 5608-5616
Authors:
Linggood, R
Govern, F
Coleman, CN
Citation: R. Linggood et al., Report from the field - A blueprint for linking academic oncology and the community, J HEALTH P, 23(6), 1998, pp. 973-994
Risultati:
1-15
|